Abstract
Babu Rankupalli
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Lessons to take home from CATIE
10.1176/ps.2008.59.5.523 · 2008
First- and second-generation antipsychotics and the concept of “atypicality”: implications for clinical practice
10.1097/01.idt.0000360999.60168.a4 · 2009
Schizophrenia, clinical antipsychotic trials of intervention effectiveness (CATIE), and number needed to treat: how can CATIE inform clinicians?
10.1111/j.1742-1241.2006.01044.x · 2006
Unresolved referenced work
1979
Effectiveness of switching antipsychotic medications
10.1176/ajp.2006.163.12.2090 · 2006
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics
10.1176/appi.ajp.163.2.185 · 2006
The environment and disease: association or causation
1962
Some main problems eroding the credibility and relevance of randomized trials
2008
Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine tools
10.1185/030079907x233269 · 2007
Are certain multi-center randomized clinical trials structures misleading clinical and policy decisions?
10.1016/j.cct.2005.05.002 · 2005
Clinical trials design lessons from the CATIE study
10.1176/appi.ajp.2009.08121809 · 2009
CATIE CUtLASS: can we handle the truth?
10.1192/bjp.bp.107.037218 · 2008
Effectiveness of antipsychotics in patients with chronic schizophrenia
10.1056/nejmoa051688 · 2005
Interpreting the efficacy findings in the CATIE study: what the clinician should know
10.1017/s109285290002664x · 2006
Extrapyramidal side-effects of antipsychotics in a randomised trial
10.1192/bjp.bp.108.050088 · 2008
Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study
10.1007/s00406-005-0634-2 · 2005
Randomized controlled trials in psychiatry. Part II. Their relationship to clinical practice
10.1046/j.1440-1614.2003.01176.x · 2003
Cleaning up evidence-based psychopharmacology
10.1097/01.idt.0000311517.65367.cf · 2008
What CATIE did: some thoughts deep and wide
10.1176/ps.2008.59.5.530 · 2008
Unresolved referenced work
2000
Unresolved referenced work
2002
Establishing the internal and external validity of experimental studies
10.1093/ajhp/58.22.2173 · 2001
Strategies for maximizing clinical effectiveness in the treatment of schizophrenia
10.1097/00131746-200611000-00003 · 2006
First- and second-generation antipsychotics: learning from CATIE and CUtLASS
10.1001/archpsyc.64.8.977 · 2007
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
10.1016/j.schres.2007.11.033 · 2008
No additional external references are available.